Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily vs Thrice-Weekly TMS for PCP Prophylaxis in HIV
NCT00000748Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trimethoprim + sulfamethoxazole in Pneumocystis pneumonia (PCP), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
Pneumocystis pneumonia (PCP)
Beyond the preview
Go deeper on NCT00000748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000748.